代表 SFGM-TC：第三方病毒特异性 T 细胞转移在免疫受损移植患者中的实际应用。 - Suppr

On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.

作者信息

Leroyer Esther Hazane, Petitpain Nadine, Morisset Stéphane, Neven Bénédicte, Castelle Martin, Winter Sarah, Souchet Laetitia, Morel Véronique, Le Cann Marie, Fahd Mony, Yacouben Karima, Mechinaud Françoise, Ouachée-Chardin Marie, Renard Cécile, Wallet Hélène Labussière, Angoso Marie, Jubert Charlotte, Chevallier Patrice, Léger Alexandra, Rialland Fanny, Dhedin Nathalie, Robin Christine, Maury Sébastien, Beckerich Florence, Beauvais David, Cluzeau Thomas, Loschi Michaël, Fernster Alina, Bittencourt Marcelo De Carvalho, Cravat Maxime, Bilger Karin, Clément Laurence, Decot Véronique, Gauthier Mélanie, Legendre Anne, Larghero Jérôme, Ouedrani Amani, Martin-Blondel Guillaume, Pochon Cécile, Reppel Loïc, Rouard Hélène, Nguyen-Quoc Stéphanie, Dalle Jean-Hugues, D'Aveni Maud, Bensoussan Danièle

机构信息

Department of Hematology Nancy University Hospital Vandoeuvre-les-Nancy France.

Regional Centre of Pharmacovigilance Nancy University Hospital Vandoeuvre-les-Nancy France.

出版信息

Hemasphere. 2024 Jan 27;8(1):e40. doi: 10.1002/hem3.40. eCollection 2024 Jan.

DOI:10.1002/hem3.40

PMID:38434523

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10878191/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca6/10878191/4b0f514f00b6/HEM3-8-e40-g001.jpg

相似文献

On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.

Hemasphere. 2024 Jan 27;8(1):e40. doi: 10.1002/hem3.40. eCollection 2024 Jan.

[Sexual and emotional life after allogeneic hematopoietic stem cell transplant: Guidelines and patient booklet from the Francophone Society of Bone marrow Transplant and Cellular therapy (SFGM-TC)].

Bull Cancer. 2020 Dec;107(12S):S151-S158. doi: 10.1016/j.bulcan.2020.05.012. Epub 2020 Jul 31.

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.

Leukemia. 2017 Oct;31(10):2161-2171. doi: 10.1038/leu.2017.16. Epub 2017 Jan 16.

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.

J Hematol Oncol. 2017 May 8;10(1):102. doi: 10.1186/s13045-017-0469-0.

Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.

Eur J Haematol. 2015 May;94(5):449-55. doi: 10.1111/ejh.12451. Epub 2014 Oct 13.

[How we harmonize HSCT clinical practices among the SFGM-TC centers].

Bull Cancer. 2016 Nov;103(11S):S193-S197. doi: 10.1016/j.bulcan.2016.09.006. Epub 2016 Oct 31.

[Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Bull Cancer. 2021 Dec;108(12S):S90-S97. doi: 10.1016/j.bulcan.2021.11.001. Epub 2021 Dec 6.

Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.

Transplant Cell Ther. 2022 Feb;28(2):116.e1-116.e7. doi: 10.1016/j.jtct.2021.11.005. Epub 2021 Nov 14.

Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC).

Bone Marrow Transplant. 2022 Jan;57(1):125-127. doi: 10.1038/s41409-021-01477-6. Epub 2021 Oct 7.

[Transfer of allogeneic stem cell transplant recipients to the intensive care unit: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

Bull Cancer. 2016 Nov;103(11S):S220-S228. doi: 10.1016/j.bulcan.2016.09.008. Epub 2016 Nov 2.

引用本文的文献

Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context.

Front Immunol. 2025 Jan 15;15:1527648. doi: 10.3389/fimmu.2024.1527648. eCollection 2024.

本文引用的文献

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.

Clin Cancer Res. 2023 Jan 17;29(2):324-330. doi: 10.1158/1078-0432.CCR-22-2415.

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.

Blood Adv. 2022 Sep 13;6(17):4949-4966. doi: 10.1182/bloodadvances.2022007103.

Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.

Bone Marrow Transplant. 2022 May;57(5):742-752. doi: 10.1038/s41409-022-01604-x. Epub 2022 Feb 22.

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.

Bone Marrow Transplant. 2021 Jul;56(7):1651-1664. doi: 10.1038/s41409-021-01227-8. Epub 2021 Feb 23.

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.

J Clin Invest. 2020 Feb 3;130(2):733-747. doi: 10.1172/JCI121127.

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors.

Bone Marrow Transplant. 2020 Jan;55(1):126-136. doi: 10.1038/s41409-019-0624-z. Epub 2019 Aug 27.

Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities.

Bone Marrow Transplant. 2020 Jan;55(1):25-39. doi: 10.1038/s41409-019-0548-7. Epub 2019 May 14.

Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study.

Eur J Haematol. 2019 Mar;102(3):210-217. doi: 10.1111/ejh.13194. Epub 2019 Jan 11.

Management of adenovirus infection in patients after haematopoietic stem cell transplantation: State-of-the-art and real-life current approach: A position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation.

Rev Med Virol. 2018 May;28(3):e1980. doi: 10.1002/rmv.1980. Epub 2018 Apr 16.

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.

Blood Adv. 2017 Nov 2;1(24):2193-2205. doi: 10.1182/bloodadvances.2017010223. eCollection 2017 Nov 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献